Delayed a total of 6 times on the way to its final release worldwide this week, Sony and Marvel’s collaboration to bring their pro-hero Dr. Michael Morbius to life was one of those damned productions that was doomed from the start. And seeing this toothless and spineless comic book adaptation hit the big screen, it’s safe to say that the world would be a lot better if Morbius had stayed with the delay permanently.
An incredibly inept feature from director Daniel Espinosa, who somehow makes Hollywood movies with significant budgets and name brand casts, despite never actually directing a good movie, Morbius far more than most brands associated with the Marvel name. Feels too far off as a $75 million dollar budget. As the blur of video games like CGI is nowhere to be found on screen, the amateurishly scripted visuals and poorly acted characters clog the movies to lifeless 100-minute runtimes that can’t be ended quickly.
Failing as an origin story, with Michael’s entire history set-up in a cringe-worthy flashback scene, a disturbing vampire story, and an action comic book film, it’s hard to know what Morbius thought. That’s what it’s doing with its potentially entertaining material. Espinosa gives his lead man Jared Leto another high-profile role, which gets us to question his talent as Hollywood’s leading man, while He makes sure as a director that Morbius is nothing but an enigma of a character lost in a diabolical tale who barely remembers minutes after exiting the cinema.
Sometimes with films that fail miserably like Morbius’s, there are bits of what might have been found within them, moments that show not all hope, but the kind of blockbusters of Espinosa and Leto. Not With That, which really has no moment to escape. Its grim, shaky cam matches the cinematic nonsense with the only slight glimpse of a better film to come from Matt Smith’s villainous Milo (yes, that’s what he’s called). The entire film is called, Meet) the well-liked Dr. Joe at least seems to be having fun with his role while everyone else is as enthusiastic as the bloodthirsty going to his coffin for a day’s nap.
Undoubtedly developed by Sony and Marvel with both Venom and Spider-Man properties likely to play an important role in the future, it’s hard to imagine how excited anyone would be to walk away from it when it comes to having more Morbius appearances in the biggest. Speaking of possibility. The movie brand name continues to go around and despite the mid-credits effort still excites audiences about what the near future might hold for Leto’s charisma-free biochemist, most only to escape through the exit door. Which is probably the worst Marvel movie we’ve seen yet.
final say –
Things never looked good for poor old Morbius, but even the most pessimistic of pundits couldn’t expect a movie like the one we get here, a DOA offering without purpose, intent, or creativity, to be sure Marvel Morbius will do well. From a very long and hidden sleep, he never wakes up again.
Greetings again from the dark. He said, trust the science. Dr. Michael Morbius is a brilliant physician/scientist who has dedicated his life to treating the rare and crippling blood disease he and his friend Milo were born with. It is an origin story taken from Marvel comic book characters created by Roy Thomas and Gil Kane. The film is directed by Danielle Espinosa (Life 2017, Safe House 2012), with a script adapted by Matt Sazama and Burke Sharpless, who previously worked on Dracula Untold (2014), The Last Witch Hunter (2015) and Gods of Egypt (2016). )
had cooperated. Sometimes past work tells you what you need to know.
There are always good shots of a helicopter dodging the waters and rocks of Costa Rica, with zillions (I counted) of vampire bats living in it, before landing at the mouth of a cave in an early sequence. The brilliant Dr. Morbius plans to mix the vampire’s blood with human blood in his latest attempt to find a cure. All of his work is funded by the ultra-rich and equally afflicted Milo, both men desperate for relief from their deteriorating bodies.
We flashback to 25 years ago in a clinic in Greece where young Michael (Charlie Shotwell, Captain Fantastic, 2016) and Milo (Joseph Anson) meet for the first time as they are treated regularly by Dr. Nicholas (Jared Harris, “Mad Men”) Being done with blood transfusion) )
Jared Leto stars as Dr. Michael Morbius, better known in Marvel Comics as “The Living Vampire”, so we kinda know where things are going. It’s a surprisingly subdued performance by an actor known for his characterization whatever the case. His grown-up friend Milo is played by the always-entertaining Matt Smith, and Morbius’ love interest and research partner is Dr. Martyn Bancroft (a quintessential Adria Ariana).
You’ve probably guessed that blood mixing works… well until it turns Morbius into a bloodthirsty killing machine. This places FBI agents on the trail played by Tyrese Gibson and (Master of the Wise) Al Madrigal. And yes, we know it’s headed to the high afternoon (or midnight) showdown between childhood blood buddies and it’s Morbius vs. ‘Hey, I love this supernatural power’ meet.
The first volume of the film does a splendid job of setting the stage, but the story, characters and execution leave us disappointed for the final two acts. The fight scenes have some of the worst special effects I’ve seen in years. Sure, the film’s release has been delayed by a few years, but that’s no excuse for what we see. On the bright side, some of the effects work, and Matt Smith has fun watching some of his scenes.
We wish for more of Martin’s story, and for a better story overall (after the introduction). The film is part of SSU (Sony Spider-Man Universe) and perhaps the best comparison is Venom, without the chuckle. It is clear that the mission of this film was to set the stage for a sequel, and this becomes even more apparent in the mid-credits scenes. Normally, I wouldn’t mention it, but since the director has already discussed it, and an appearance was made in Spider-Man: No Way Home, I believe it’s fair game. The great Michael Keaton pops in as Adrian Toomes (aka Vulture), giving us a clue as to where the sequel is headed.